Vivli Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Vivli's estimated annual revenue is currently $1.1M per year.(i)
  • Vivli's estimated revenue per employee is $55,080

Employee Data

  • Vivli has 20 Employees.(i)
  • Vivli grew their employee count by 18% last year.

Vivli's People

NameTitleEmail/Phone
1
CEO, Vivli, Center for Global Data ResearchReveal Email/Phone
2
CTOReveal Email/Phone
3
Director Technical OperationsReveal Email/Phone
4
Senior Clinical Research ManagerReveal Email/Phone
5
Senior Statistical AdvisorReveal Email/Phone
6
Technical Operations EngineerReveal Email/Phone
7
Principal Software EngineerReveal Email/Phone
8
Executive AssistantReveal Email/Phone
9
Technical Operations EngineerReveal Email/Phone
10
Senior Software ArchitectReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M160%N/AN/A
#2
$13.4M120-1%N/AN/A
#3
$42.8M3360%N/AN/A
#4
$7.8M711%N/AN/A
#5
$8.2M72-3%N/AN/A
#6
$0.1M6-25%$1.9MN/A
#7
$5.7M6412%N/AN/A
#8
$0.9M12-8%N/AN/A
#9
$25.2M2153%N/AN/A
#10
N/A5323%N/AN/A
Add Company

What Is Vivli?

Vivli – Global Clinical Trials Data Sharing Platform Our mission: Promote, coordinate, and facilitate clinical research data sharing through the creation and implementation of a sustainable global data-sharing enterprise.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$1.1M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vivli News

2022-04-19 - Efficacy of once-weekly tirzepatide versus once-daily insulin ...

For details on submitting a request, see the instructions provided at http://www.vivli.org. Declaration of interests. TB has received honoraria...

2022-02-22 - NIH Initiative Seeks to Improve Access to NIH-Funded Data

The six GREI repositories are: • Dryad • Dataverse • Figshare • Mendeley Data • Open Science Framework • Vivli...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M20-9%$69M
#2
$2.5M20-17%N/A
#3
$2.9M20N/AN/A
#4
$1.5M20-47%N/A
#5
$3.1M2011%N/A